South China Morning PostMarker for cancer stem cells—Fluorescent probe identifies tumor-initiating cellsPhys.OrgAlthough there are markers that also recognize TICs associated with some types of cancer, no universal, selective probe for cancer stem cell… Continue reading
Healio |
Surgeon meets challenges of performing gene therapy
Healio On March 22, a Florida boy underwent gene therapy with Luxturna for treatment of inherited retinal disease at the Bascom Palmer Eye Institute, a first for the institution. “Of course there were challenges,” the boy’s surgeon, Audina M. Berrocal, MD … |
Nasdaq |
Pfizer Inks New CAR–T Deal, In Talks With P&G for Unit Sale
Nasdaq Focus on the CAR-T area has increased with last year’s FDA approval of therapies such as Novartis’ NVS Kymriah and Gilead’s Yescarta. These treatments have huge commercial potential and could well change the treatment paradigm. CAR-T falls under the … |
Futurity: Research News |
CRISPR and DNA ‘barcode’ track cancer growth
Futurity: Research News Scientists have found a way to modify pairs of cancer-related genes in the lungs of mice and then precisely track individual cells of the resulting tumor. The combined technique could dramatically speed up cancer research and drug development, finally … |
Cosmos |
Editor’s note: We live in interesting times thanks to biological tools
Cosmos The biologists’ tool kit may also help blunt the effects of our insatiable appetite for energy and commodities. Solar and wind power will supply ever more energy, but we will still need fuels to power the likes of aeroplanes and feed industrial … |
|
What We’re Reading: 2018 ACA Enrollment; Spread of Rare Superbug; Off-the-Shelf CAR T Therapies
AJMC.com Managed Markets Network Chimeric antigen receptor (CAR) T-cell therapies need to be personalized to each patient, but a new company is looking to develop off-the-shelf therapies that do not need to be personalized. Allogene Therapeutics was launched Tuesday by 2 former … |